Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001671311-25-000009

Chief Operating Officer sold 21,208 shares at an average $22.01 ($466,870)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jarrett Jennifer · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-16 Sale : show line 1 in the form 10b5-1 −11,225 $21.88 $245,651 203,007 D
2025-12-17 Sale : show line 2 in the form 10b5-1 −9,983 $22.16 $221,218 193,024 D
Open-market sales · 21,208 sh · avg $22.01 · $466,870
Loading xslF345X05/wk-form4_1766097311.xml…